Wolfram Syndrome
This study is an open label Phase II study to evaluate the safety and efficacy of AMX0035 in adults with Wolfram syndrome.
AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.
Free account
You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.